People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Other Technology, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MC10, Inc. | — | Other Technology | Series B | $145.5M | $75.2M | 2015 |
| Precision Dermatology, Inc. | — | Other Health Care | Series C | $103.4M | $1.3B | 2010 |
| Collegium Pharmaceutical, Inc | — | Pharmaceuticals | Series C | $97.5M | $701.8M | 2010 |
Steven N. Tannenbaum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven N. Tannenbaum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick N. Heron | 2 | 3 |
| John Rogers | 1 | 20 |
| David Hirsch | 1 | 16 |
| Carmichael Roberts | 1 | 15 |
| Patrick Heron | 1 | 11 |
| John Freund | 1 | 7 |
| Stephen Hoffman | 1 | 7 |
| Patrick J. Heron | 1 | 7 |
| Paul Klingenstein | 1 | 6 |
| Gino Santini | 1 | 5 |
| Jiong Ma | 1 | 5 |
| George Whitesides | 1 | 5 |
| Michael Heffernan | 1 | 5 |
| Marc Singer | 1 | 5 |
| Paul Bleicher | 1 | 4 |
| Eran Nadav | 1 | 4 |
| Paul Brannelly | 1 | 4 |
| Patrick M. Heron | 1 | 3 |
| Gino W. Santini | 1 | 3 |
| Theodore A Schroeder | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.